A new agent (hydrophilic fraction of polypodium leucotomos) for management of psoriasis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006027:Glycosides / Q000627:therapeutic use*; D006601:Hexoses / Q000627:therapeutic use; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D010919:Placebos; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D051381:Rats; D014315:Triterpenes / Q000627:therapeutic use
D006027:Glycosides; D006601:Hexoses; D010919:Placebos; D014315:Triterpenes